35 results
Page 2 of 2
8-K
EX-10.1
b7op5sqt4pm7yim
2 Mar 21
Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
9:00am
424B4
nsbwynkvs6soh
26 Jun 20
Prospectus supplement with pricing info
4:47pm
S-1/A
mzpqb0ovt2d1bjx6qzml
22 Jun 20
IPO registration (amended)
6:16am
S-1/A
EX-10.3
rjqg ifj87a5oq
22 Jun 20
IPO registration (amended)
6:16am
S-1/A
EX-1.1
nhs94
22 Jun 20
IPO registration (amended)
6:16am
S-1
t6od5g
5 Jun 20
IPO registration
4:16pm
S-1
EX-10.11
g351s6w
5 Jun 20
IPO registration
4:16pm
S-1
EX-4.1
wkgx2kv slgc1
5 Jun 20
IPO registration
4:16pm
S-1
EX-10.1
9g3 76gsg866phalp7tb
5 Jun 20
IPO registration
4:16pm
DRS/A
EX-10.1
oeyfdqv
14 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-4.1
0ywj25x ru
14 May 20
Draft registration statement (amended)
12:00am
DRS/A
ss2nj8mw4inthi 8z
14 May 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.11
sdv2g34nwkhd7n
14 May 20
Draft registration statement (amended)
12:00am
DRS
algfqax0
3 Apr 20
Draft registration statement
12:00am